Patents by Inventor Hiroyoshi Kawada

Hiroyoshi Kawada has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Substituted guanidine compounds
    Patent number: 11814393
    Abstract: The present invention provides a compound of general formula (I) (wherein X is as described in the present description and claims), or a pharmacologically acceptable salt thereof, and a pharmaceutical composition containing that compound.
    Type: Grant
    Filed: June 16, 2022
    Date of Patent: November 14, 2023
    Assignee: UBE CORPORATION
    Inventors: Ken-Ichi Komori, Akishi Ninomiya, Masaru Shinohara, Koji Ito, Tetsuo Kawaguchi, Hiroyoshi Kawada, Tomio Kimura
  • SUBSTITUTED GUANIDINE COMPOUNDS
    Publication number: 20220315599
    Abstract: The present invention provides a compound of general formula (I) (wherein X is as described in the present description and claims), or a pharmacologically acceptable salt thereof, and a pharmaceutical composition containing that compound.
    Type: Application
    Filed: June 16, 2022
    Publication date: October 6, 2022
    Inventors: Ken-Ichi KOMORI, Akishi NINOMIYA, Shigeru USHIYAMA, Masaru SHINOHARA, Koji ITO, Tetsuo KAWAGUCHI, Yasunori TOKUNAGA, Hiroyoshi KAWADA, Haruka YAMADA, Yusuke SHIRAISHI, Masahiro KOJIMA, Masaaki ITO, Tomio KIMURA
  • BENZOTRIAZOLE DERIVATIVE
    Publication number: 20220259223
    Abstract: The present invention provides a compound having Keap1 inhibitory effects and a pharmaceutical composition containing the same. Specifically, the present invention provides a compound represented by the following general formula (I): [wherein the symbols have the same meanings as those described in the description] or a pharmaceutically acceptable salt thereof and a pharmaceutical composition containing the same.
    Type: Application
    Filed: May 29, 2020
    Publication date: August 18, 2022
    Applicant: UBE INDUSTRIES, LTD.
    Inventors: Ken-ichi KOMORI, Hayato NISHIYAMA, Naoya KINOSHITA, Yukinori WADA, Kousuke MORISHITA, Akishi NINOMIYA, Yuusuke SHIRAISHI, Kazuhiro ONUMA, Sayaka OGI, Hiroyoshi KAWADA, Tomio KIMURA
  • Substituted guanidine compounds
    Patent number: 11396514
    Abstract: The present invention provides a compound of general formula (I) (wherein X is as described in the present description and claims), or a pharmacologically acceptable salt thereof, and a pharmaceutical composition containing that compound.
    Type: Grant
    Filed: December 27, 2017
    Date of Patent: July 26, 2022
    Inventors: Ken-ichi Komori, Akishi Ninomiya, Shigeru Ushiyama, Masaru Shinohara, Koji Ito, Tetsuo Kawaguchi, Yasunori Tokunaga, Hiroyoshi Kawada, Haruka Yamada, Yusuke Shiraishi, Masahiro Kojima, Masaaki Ito, Tomio Kimura
  • Substituted guanidine derivatives
    Patent number: 10759781
    Abstract: The present invention provides a compound of general formula (I) (wherein, R1, X, p and q are as described in the present description and claims), or a pharmacologically acceptable salt thereof, and a pharmaceutical composition containing that compound.
    Type: Grant
    Filed: August 5, 2016
    Date of Patent: September 1, 2020
    Assignee: UBE INDUSTRIES, LTD.
    Inventors: Ken-ichi Komori, Akishi Ninomiya, Shigeru Ushiyama, Masaru Shinohara, Koji Ito, Tetsuo Kawaguchi, Yasunori Tokunaga, Hiroyoshi Kawada, Haruka Yamada, Yusuke Shiraishi, Masahiro Kojima, Masaaki Ito, Tomio Kimura
  • SUBSTITUTED GUANIDINE COMPOUNDS
    Publication number: 20190337962
    Abstract: The present invention provides a compound of general formula (I) (wherein X is as described in the present description and claims), or a pharmacologically acceptable salt thereof, and a pharmaceutical composition containing that compound.
    Type: Application
    Filed: December 27, 2017
    Publication date: November 7, 2019
    Applicant: UBE INDUSTRIES, LTD.
    Inventors: Ken-ichi KOMORI, Akishi NINOMIYA, Shigeru USHIYAMA, Masaru SHINOHARA, Koji ITO, Tetsuo KAWAGUCHI, Yasunori TOKUNAGA, Hiroyoshi KAWADA, Haruka YAMADA, Yusuke SHIRAISHI, Masahiro KOJIMA, Masaaki ITO, Tomio KIMURA
  • SUBSTITUTED GUANIDINE DERIVATIVES
    Publication number: 20190152953
    Abstract: The present invention provides a compound of general formula (I) (wherein, R1, X, p and q are as described in the present description and claims), or a pharmacologically acceptable salt thereof, and a pharmaceutical composition containing that compound.
    Type: Application
    Filed: August 5, 2016
    Publication date: May 23, 2019
    Applicant: UBE INDUSTRIES, LTD.
    Inventors: Ken-ichi KOMORI, Akishi NINOMIYA, Shigeru USHIYAMA, Masaru SHINOHARA, Koji ITO, Tetsuo KAWAGUCHI, Yasunori TOKUNAGA, Hiroyoshi KAWADA, Haruka YAMADA, Yusuke SHIRAISHI, Masahiro KOJIMA, Masaaki ITO, Tomio KIMURA
  • Remedy for corneal diseases
    Patent number: 8318739
    Abstract: The present invention provides a method for treating a corneal disease by administering to a patient in need of such treatment an effective amount of ozagrel or a salt thereof.
    Type: Grant
    Filed: July 1, 2010
    Date of Patent: November 27, 2012
    Assignee: Teika Pharmaceutical Co., Ltd.
    Inventors: Takahito Kimura, Shigeto Fujishita, Hiroyoshi Kawada
  • Therapeutic agent for corneal disease
    Patent number: 8268824
    Abstract: A therapeutic agent for a corneal disease comprising irsogladine or a salt thereof as an active ingredient. The purpose is to find a substance capable of effectively treating/ameliorating a corneal disease which has been increased in the number of cases thereof in recent years and to provide a therapeutic agent for a corneal disease comprising the substance as an active ingredient.
    Type: Grant
    Filed: January 12, 2010
    Date of Patent: September 18, 2012
    Assignee: Teika Pharmaceutical Co., Ltd.
    Inventors: Takahito Kimura, Shigeto Fujishita, Hiroyoshi Kawada
  • REMEDY FOR CORNEAL DISEASES
    Publication number: 20100267665
    Abstract: The present invention provides a method for treating a corneal disease by administering to a patient in need of such treatment an effective amount of ozagrel or a salt thereof.
    Type: Application
    Filed: July 1, 2010
    Publication date: October 21, 2010
    Applicant: TEIKA PHARMACEUTICAL CO., LTD.
    Inventors: Takahito Kimura, Shigeto Fujishita, Hiroyoshi Kawada
  • THERAPEUTIC AGENT FOR CORNEAL DISEASE
    Publication number: 20100113456
    Abstract: A therapeutic agent for a corneal disease comprising irsogladine or a salt thereof as an active ingredient. The purpose is to find a substance capable of effectively treating/ameliorating a corneal disease which has been increased in the number of cases thereof in recent years and to provide a therapeutic agent for a corneal disease comprising the substance as an active ingredient.
    Type: Application
    Filed: January 12, 2010
    Publication date: May 6, 2010
    Applicant: TEIKA PHARMACEUTICAL CO., LTD.
    Inventors: Takahito Kimura, Shigeto Fujishita, Hiroyoshi Kawada
  • REMEDY FOR CORNEAL DISEASES
    Publication number: 20090247600
    Abstract: A therapeutic agent for a corneal disease comprising ozagrel or a salt thereof as an active ingredient is provided. The purpose is to find a substance capable of effectively treating/ameliorating a corneal disease which has been increased in the number of cases thereof in recent years and to provide a therapeutic agent for a corneal disease comprising the substance as an active ingredient.
    Type: Application
    Filed: August 24, 2006
    Publication date: October 1, 2009
    Applicant: TEIKA PHARAMACEUTICAL CO., LTD.
    Inventors: Takahito Kimura, Shigeto Fujishita, Hiroyoshi Kawada
  • THERAPEUTIC AGENT FOR CORNEAL DISEASE
    Publication number: 20090030001
    Abstract: A therapeutic agent for a corneal disease comprising irsogladine or a salt thereof as an active ingredient. The purpose is to find a substance capable of effectively treating/ameliorating a corneal disease which has been increased in the number of cases thereof in recent years and to provide a therapeutic agent for a corneal disease comprising the substance as an active ingredient.
    Type: Application
    Filed: April 27, 2006
    Publication date: January 29, 2009
    Applicant: TEIKA PHARMACEUTICAL CO., LTD.
    Inventors: Takahito Kimura, Shigeto Fujishita, Hiroyoshi Kawada